2024
American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey
Barnett B, Arakelian M, Beebe D, Ontko J, Riegal C, Siu W, Weleff J, Pope H. American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey. Psychedelic Medicine 2024, 2: 1-9. DOI: 10.1089/psymed.2023.0036.Peer-Reviewed Original ResearchSubstance use disordersAmerican psychiatristsClassic hallucinogensPsychiatric conditionsTreatment-resistant depressionTreat psychiatric conditionsMultivariate logistic regression modelFollow-up surveyResponding psychiatristsPsychiatrists' opinionsTherapeutic potentialLogistic regression modelsUnited States Food and Drug AdministrationStates Food and Drug AdministrationHallucinogensPsychiatristsFood and Drug AdministrationPublished national surveysIncreased optimismDecreased concernAssessment attributesSurvey responsesNon-parametric trend testSurvey instrumentRegression models
2022
Management of Phenibut Use Disorder and Withdrawal in a Geriatric Patient
Wainblat E, Weleff J, Anand A. Management of Phenibut Use Disorder and Withdrawal in a Geriatric Patient. American Journal Of Geriatric Psychiatry 2022, 31: 67-74. PMID: 36266201, DOI: 10.1016/j.jagp.2022.09.008.Peer-Reviewed Original ResearchConceptsUse disorderAlcohol use disorderAnxiolytic use disorderWorsen affective disordersAffective disordersPhysiological dependenceMisuse substancesNootropic propertiesWithdrawal managementAlleviate anxietyFood and Drug AdministrationDisordersPhenibutWithdrawalAddictionClinical effectsGeriatric patientsDrug AdministrationGeriatric populationDrug profileAlcoholAnxietyBenzodiazepinesAnxiolysisInsomnia